Roivant Sciences (ROIV) Income from Non-Controlling Interests (2020 - 2026)
Roivant Sciences (ROIV) reported Income from Non-Controlling Interests of -$100.77 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$50.56 million a year earlier.
Powered by 
Analysis
Roivant Sciences (ROIV) Income from Non-Controlling Interests (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Roivant Sciences' Income from Non-Controlling Interests came in at -$148.35 million; for FY2026 (ended Mar 31, 2026), it was -$98.14 million.
- By fiscal year, Income from Non-Controlling Interests came in at -$184.75 million in FY2025, -$117.72 million in FY2024, -$106.43 million in FY2023 and -$78.85 million in FY2022.
- The fiscal Q1 2027 figure ranks as the lowest quarterly Income from Non-Controlling Interests in data going back to fiscal Q1 2021.
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $52.75 million (Q4 2026), -$47.81 million (Q3 2026) and -$52.52 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | - |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Roivant Sciences | 26.42 Bn | 9.37 Bn | 1.16 Mn | -100.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -100.77 Mn |
| Mar 31, 2026 | 52.75 Mn |
| Dec 31, 2025 | -47.81 Mn |
| Sep 30, 2025 | -52.52 Mn |
| Jun 30, 2025 | -50.56 Mn |
| Mar 31, 2025 | -45.90 Mn |
| Dec 31, 2024 | -51.31 Mn |
| Sep 30, 2024 | -49.74 Mn |
| Jun 30, 2024 | -37.81 Mn |
| Mar 31, 2024 | -31.38 Mn |
| Dec 31, 2023 | -23.52 Mn |
| Sep 30, 2023 | -26.79 Mn |
| Jun 30, 2023 | -36.03 Mn |
| Mar 31, 2023 | -27.25 Mn |
| Dec 31, 2022 | -32.88 Mn |
| Sep 30, 2022 | -24.33 Mn |
| Jun 30, 2022 | -21.98 Mn |
| Mar 31, 2022 | -21.25 Mn |
| Dec 31, 2021 | -21.55 Mn |
| Sep 30, 2021 | -17.16 Mn |
API Access
Roivant Sciences Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();